Patents for C12R 1 - Micro-organisms (92,025) |
---|
11/02/1995 | CA2188159A1 Chondroitinases i and ii, methods of preparation, and use thereof |
11/02/1995 | CA2187920A1 Spider neurotoxins and method of producing the same |
10/31/1995 | US5463175 Glyphosate tolerant plants |
10/31/1995 | US5463038 Method of producing kestose crystals |
10/31/1995 | US5463026 Anti-human prohibitin antibodies |
10/31/1995 | US5463025 Protein having human plasmin inhibiting activity |
10/31/1995 | US5462925 Transforming growth factor β2,3 |
10/31/1995 | US5462868 Cocaine esterase from Pseudomonas sp. NCIMB 40427 for detection of cocaine |
10/31/1995 | US5462864 Manufacturing method of high purity maltose and its reduced product |
10/31/1995 | US5462862 Antibiotics from microorganisms |
10/31/1995 | US5462856 Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins |
10/31/1995 | US5462855 Method for the detection and quantitative determination of nitrosomonas strains in wastewaters or soils |
10/26/1995 | WO1995028500A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
10/26/1995 | WO1995028493A1 Aav-mediated delivery of dna to cells of the nervous system |
10/26/1995 | WO1995028487A2 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
10/26/1995 | WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
10/26/1995 | WO1995028481A1 Conserved t-cell receptor sequences |
10/26/1995 | WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
10/26/1995 | WO1995028085A1 Composition and method for controlling plant diseases |
10/26/1995 | WO1995027047A3 Highly-purified recombinant reverse transcriptase |
10/26/1995 | CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases |
10/26/1995 | CA2188317A1 Nucleic acids and methods for the discrimination between syncytium inducing and non syncytium inducing variants of the human immunodeficiency virus |
10/26/1995 | CA2188316A1 Recombinant pgp3, methods of preparation and use in diagnosis and therapy |
10/26/1995 | CA2188182A1 Conserved t-cell receptor sequences |
10/26/1995 | CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy |
10/25/1995 | EP0678744A2 Method for detecting urinary tumor associated antigens |
10/25/1995 | EP0678582A1 Detection of nucleic acid amplification |
10/25/1995 | EP0678578A2 Multiple drug resistance gene of Aureobasidium pullulans |
10/25/1995 | EP0678524A1 Anti-human soluble fibrin antibody hybridoma, and immunoassaying method |
10/25/1995 | EP0678522A1 Insulin analogs |
10/25/1995 | EP0678122A1 Recombinant anti-vla4 antibody molecules |
10/25/1995 | EP0678121A1 Methods and reagents for inhibiting furin endoprotease |
10/25/1995 | EP0678101A1 Growth differentiation factor-9 |
10/25/1995 | EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN |
10/24/1995 | US5461036 Treating colon, gastric, esophageal cancer |
10/24/1995 | US5460978 Protein active in humoral hypercalcemia of malignancy-PthrP |
10/24/1995 | US5460963 Plants transformed with a DNA sequence from Bacillus thuringiensis lethal to Lepidoptera |
10/24/1995 | US5460958 Process for producing L-isoleucine by S-2-aminoethyl-L-cysteine or D-Serine resistant strains of E coli |
10/24/1995 | US5460953 Vectors and compounds for expression of glycosylation mutants of human protein C |
10/24/1995 | US5460952 Gene expression system comprising the promoter region of the α-amylase genes |
10/24/1995 | US5460949 Method and composition for increasing the accumulation of squalene and specific sterols in yeast |
10/24/1995 | US5460947 Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas |
10/24/1995 | US5460815 Culturing Crandall Feline Kidney cells infected with Dahlberg strain feline infectious peritonitis virus in serum containing growth medium, transferring it to serum-free growth medium, separating viral precursor immunogens, inactivating live virus |
10/24/1995 | CA1337408C Soluble phosphorylated glucan |
10/21/1995 | CA2147110A1 Multiple drug resistance gene of aureobasidium pullulans |
10/19/1995 | WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II) |
10/19/1995 | WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III) |
10/19/1995 | WO1995027790A2 DNA SEQUENCES CODING FOR A CYNNAMOYL CoA REDUCTASE AND THEIR USE IN THE REGULATION OF PLANT LIGNIN CONCENTRATIONS |
10/19/1995 | WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
10/19/1995 | WO1995027784A1 Cisplatin resistance gene and uses therefor |
10/19/1995 | WO1995027781A1 Superoxide dismutase-4 |
10/19/1995 | WO1995027730A1 New thiodepsipeptide isolated from a marine actinomycete |
10/19/1995 | WO1995027507A1 Immunodeficiency recombinant poxvirus |
10/19/1995 | WO1995024481A3 Humanized monoclonal antibodies against human interleukin-4 |
10/19/1995 | WO1995020658A3 Diagnosis and treatment of infections due to streptococci and enterococci |
10/19/1995 | WO1995019433A3 Anti-hepatitis b poly- and oligonucleotides |
10/19/1995 | WO1994028145A3 Expression of urokinase plasminogen activator inhibitors |
10/19/1995 | CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
10/19/1995 | CA2187635A1 Superoxide dismutase-4 |
10/19/1995 | CA2187031A1 Immunodeficiency recombinant poxvirus |
10/19/1995 | CA2185334A1 Dna sequences coding for a cynnamoyl coa reductase and their use in the regulation of plant lignin concentrations |
10/19/1995 | CA2163526A1 Cisplatin resistance gene and uses therefor |
10/18/1995 | EP0677586A1 Recombinant collagenase type II from clostridium histolyticum and its use for the isolation of cells and cellular agglomerations |
10/18/1995 | EP0677585A1 Process for the production of D-alpha-amino acids |
10/18/1995 | EP0677584A1 Stable mutants of D-N-alpha-carbamylase |
10/18/1995 | EP0677583A1 Bacillus thuringiensis isolate active against dipteran pests |
10/18/1995 | EP0677533A2 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof |
10/18/1995 | EP0677116A1 A process for producing immunosuppressives and a novel microbial species to be employed therein |
10/18/1995 | EP0677114A1 Recombinant swinepox virus |
10/18/1995 | EP0677113A1 Viral amplification of recombinant messenger rna in transgenic plants |
10/18/1995 | EP0677110A1 Recombinant lactic acid bacterium containing an inserted promoter and method of constructing same |
10/18/1995 | EP0677109A1 Expression system for producing apolipoprotein ai-m |
10/18/1995 | EP0677106A1 Leukocyte derived growth factors |
10/18/1995 | EP0677105A1 Allergenic proteins and peptides from dog dander and uses therefor |
10/18/1995 | EP0677104A1 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
10/18/1995 | EP0677063A1 A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS |
10/18/1995 | EP0677054A1 New antiparasitic agents related to the milbemycins and avermectins |
10/18/1995 | EP0676966A1 Antibodies directed against binding-associated epitopes |
10/18/1995 | EP0515415B1 Novel vaccine and method therefor |
10/18/1995 | EP0291533B1 Rna ribozyme restriction endoribonucleases and methods |
10/18/1995 | CN1110323A Novel polypeptides and DNAS encoding them |
10/17/1995 | US5459251 And a polynucleotide comprising the same that is expressed or replicated in bacteria |
10/17/1995 | US5459141 Compounds 31668P and 31668U, a process for their production and their use |
10/17/1995 | US5459128 Restenosis inhibitors |
10/17/1995 | US5459064 Derived from bacillus licheniformis, encoded by specified, purified dna sequences and cleaves peptide bonds |
10/17/1995 | US5459052 Method of producing IGF-1 |
10/17/1995 | US5459051 Genetic engineering, gene expression |
10/17/1995 | US5459043 Hybridoma CT43 producing a monoclonal antibody to a novel mucin epitope which correlates with the presence of colorectal cancer |
10/17/1995 | US5459041 Campylobacter pylori antigens and uses thereof for detection of Campylobacter pylori infection |
10/17/1995 | US5459037 Electrophoresis, change in RNA expression due to drugs, physiological or pathological conditions |
10/17/1995 | US5459036 Extracellular signal-regulated kinase, sequences, and methods of production and use |
10/17/1995 | US5459034 Difficile specific oligonucleotides |
10/17/1995 | US5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity |
10/17/1995 | CA2081689C Process for preparation of --pyrone derivatives |
10/17/1995 | CA2011020C Compositions and protocols applicable to genetic analysis |
10/17/1995 | CA1337339C Two-stage fermentation process for the production of polysaccharides |
10/17/1995 | CA1337337C Acidic polycyclic ether antibiotic having anticoccidial and growth promotant activity |
10/17/1995 | CA1337336C Human papillomavirus nucleic acid hybridization probes and methods for employing the same |
10/12/1995 | WO1995027070A1 Dna expression vectors for use in the treatment of vascular diseases by gene therapy |
10/12/1995 | WO1995027067A1 Purified dna polymerase from bacillus stearothermophilus |